Supplements | New Approaches to Measuring Value in Oncology Therapy

ARTICLES

Although clinical trial data have quantified patient survival gains associated with tyrosine kinase inhibitors in chronic myeloid leukemia, the overall value of these benefits is unknown.

AUTHOR INDEX

More issues

Compendia
Diabetes Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
$vacMongoViewPlus$